Team

There’s a lot of talk about the power of artificial intelligence and big data. A lot of talk, and a lot of promises.

Our team is grounded in experience and a track record of invention—realized. They have scaled technology businesses, fueled the adoption of new products among consumers, engaged people in their health online, and opened new markets by giving people information and tools to guide their health choices.

But our people are also grounded in the realities of what it means to push the bounds of science. They know biotech, omics, AI and data mining. They understand the complexity of molecular biology, what AI can and can’t do, and what it’s really like for people who live with and treat disease.

They’re not just talking about advancing the state of science. They’re focused on delivering real results for real people.

    Dr. Jun Wang Founder and Chief Executive Officer. Jun is responsible for the general management and business development of the company and a member of the Board of Directors. In 1999, Dr. Wang co-founded BGI, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, Nature’s 10 - the year in Science (2012), “Fortune’s 40 under 40” by Fortune Magazine (2013), “Highly Cited Researchers” (2013/2014/2015/2017) by Thomson Reuters (renamed Clarivate Analytics), “The 100 Most Creative People of 2017” by Fast Company. Dr. Wang earned a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.
    Bill W. Colston

    Chief Operating Officer. Bill leads all of the operational and technology development functions at iCarbonX and is a member of the Board of Directors. Previously he served as Chief Executive Officer and Founder of HealthTell Inc™, a company focused on developing next generation tests that broadly characterize the immune system. Before that Bill was the CEO and Scientific Founder of QuantaLife Inc., a successful biotechnology startup company that developed a highly accurate genetic analysis system that is now sold internationally. Bill started his career working at Lawrence Livermore National Laboratory, where he served in various senior leadership roles over a nearly 20-year career and helped build the first civilian biodefense program in the United States. Bill is a board member of several companies, including Rheonix, Purigen, and RubrYc, and holds a Ph.D. in Biomedical Engineering from the University of California, Davis.

    Jamie Heywood

    Chief Research Officer. Jamie oversees iCarbonX’s research activities, including data sciences and the iCX Research Institute, and is a member of the Board of Directors. When his brother Stephen was diagnosed with ALS at the age of 29, Jamie entered the field of translational medicine and founded the ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company. Jamie pioneered an open research model and industrialized a therapeutic validation process that made this biotechnology company the world’s largest and most comprehensive ALS research program. In addition to ALS TDI, Jamie has founded some of the most transformational companies in health care, including: PatientsLikeMe, the world’s largest personalized health network; AOBiome Therapeutics, a clinical-stage microbiome company developing the first mechanism-based bacterial therapeutic; Genetic Networks, a company that identifies and develops therapeutics for human diseases through network biodiscovery; and TheSocialMedwork, a social enterprise helping people access the latest medicines more quickly and in countries where medicines are not available. Jamie holds a Bachelor of Science in Mechanical Engineering from the Massachusetts Institute of Technology (MIT).


    Aldous Wong

    President, Greater China and Asia Pacific and Global Chief Commercial Officer. Aldous directs the company’s commercial strategy and manages the commercial product development, marketing, corporate development and ecosystem teams. Before joining iCarbonX, Aldous was Senior Vice President and Chief Commercial Officer for Asia Pacific at GE Digital. In that position he directed the company’s financial and business operations throughout the region and created a highly productive, revenue-generating ecosystem of customers, partners, industry leaders across a range of industries, including health care. He has also held senior management positions in China and for the Asia Pacific region at some of the world’s leading high technology companies, including Honeywell, Autodesk, Oracle and Hewlett Packard. Aldous holds a Master’s degree in Business Administration and Management from Hong Kong University of Science and Technology and is a graduate of INSEAD’s APAC Leadership Program in Singapore.

  • Founder and Chief Executive Officer. Jun is responsible for the general management and business development of the company and a member of the Board of Directors. In 1999, Dr. Wang co-founded BGI, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, Nature’s 10 - the year in Science (2012), “Fortune’s 40 under 40” by Fortune Magazine (2013), “Highly Cited Researchers” (2013/2014/2015/2017) by Thomson Reuters (renamed Clarivate Analytics), “The 100 Most Creative People of 2017” by Fast Company. Dr. Wang earned a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.
  • Chief Operating Officer. Bill leads all of the operational and technology development functions at iCarbonX and is a member of the Board of Directors. Previously he served as Chief Executive Officer and Founder of HealthTell Inc™, a company focused on developing next generation tests that broadly characterize the immune system. Before that Bill was the CEO and Scientific Founder of QuantaLife Inc., a successful biotechnology startup company that developed a highly accurate genetic analysis system that is now sold internationally. Bill started his career working at Lawrence Livermore National Laboratory, where he served in various senior leadership roles over a nearly 20-year career and helped build the first civilian biodefense program in the United States. Bill is a board member of several companies, including Rheonix, Purigen, and RubrYc, and holds a Ph.D. in Biomedical Engineering from the University of California, Davis.

  • Chief Research Officer. Jamie oversees iCarbonX’s research activities, including data sciences and the iCX Research Institute, and is a member of the Board of Directors. When his brother Stephen was diagnosed with ALS at the age of 29, Jamie entered the field of translational medicine and founded the ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company. Jamie pioneered an open research model and industrialized a therapeutic validation process that made this biotechnology company the world’s largest and most comprehensive ALS research program. In addition to ALS TDI, Jamie has founded some of the most transformational companies in health care, including: PatientsLikeMe, the world’s largest personalized health network; AOBiome Therapeutics, a clinical-stage microbiome company developing the first mechanism-based bacterial therapeutic; Genetic Networks, a company that identifies and develops therapeutics for human diseases through network biodiscovery; and TheSocialMedwork, a social enterprise helping people access the latest medicines more quickly and in countries where medicines are not available. Jamie holds a Bachelor of Science in Mechanical Engineering from the Massachusetts Institute of Technology (MIT).


  • President, Greater China and Asia Pacific and Global Chief Commercial Officer. Aldous directs the company’s commercial strategy and manages the commercial product development, marketing, corporate development and ecosystem teams. Before joining iCarbonX, Aldous was Senior Vice President and Chief Commercial Officer for Asia Pacific at GE Digital. In that position he directed the company’s financial and business operations throughout the region and created a highly productive, revenue-generating ecosystem of customers, partners, industry leaders across a range of industries, including health care. He has also held senior management positions in China and for the Asia Pacific region at some of the world’s leading high technology companies, including Honeywell, Autodesk, Oracle and Hewlett Packard. Aldous holds a Master’s degree in Business Administration and Management from Hong Kong University of Science and Technology and is a graduate of INSEAD’s APAC Leadership Program in Singapore.